Variable | |
---|---|
Primary outcomes  Time to functional recovery, n (days)  Patients with PDAC who start adjuvant chemotherapy at 8 weeks, n (%) | |
Secondary outcomes  Estimated blood loss, ml  Operative time, min  Length of hospital stay, days  30-day morbidity, n (%)   < Clavien-Dindo grade IIIa   ≥ Clavien-Dindo grade IIIb  30-day mortality, n (%)  90-day mortality, n (%)  30-day readmission, n (%)  Reoperation, n (%)  Quality of life assessment  Perioperative costs, $  In PDAC   Resection margin status, n (%)   Harvested lymph nodes, n   Positive lymph nodes, n   Recurrence, n (%)   Recurrence site, n (%)   Recurrence-free survival, months   Overall survival, months |